Endocannabinoid-mediated synaptic plasticity in the CNS

V Chevaleyre, KA Takahashi, PE Castillo - Annu. Rev. Neurosci., 2006 - annualreviews.org
Abstract Changes in synaptic efficacy are thought to be crucial to experience-dependent
modifications of neural function. The diversity of mechanisms underlying these changes is …

Endocannabinoids as regulators of transient receptor potential (TRP) channels: a further opportunity to develop new endocannabinoid-based therapeutic drugs

VD Marzo, LD Petrocellis - Current medicinal chemistry, 2010 - ingentaconnect.com
In the late 1990's, a series of experiments carried out independently in two laboratories led
to establish an important connection between the function of the endocannabinoids, which …

[HTML][HTML] Aspectos terapêuticos de compostos da planta Cannabis sativa

KM Honório, A Arroio, ABF Silva - Química nova, 2006 - SciELO Brasil
Several cannabinoid compounds present therapeutic properties, but also have psychotropic
effects, limiting their use as medicine. Nowadays, many important discoveries on the …

Endocannabinoids: a promising impact for traumatic brain injury

LD Schurman, AH Lichtman - Frontiers in pharmacology, 2017 - frontiersin.org
The endogenous cannabinoid (endocannabinoid) system regulates a diverse array of
physiological processes and unsurprisingly possesses considerable potential targets for the …

Anandamide and 2-arachidonoylglycerol: pharmacological properties, functional features, and emerging specificities of the two major endocannabinoids

A Luchicchi, M Pistis - Molecular neurobiology, 2012 - Springer
Since the discovery of endocannabinoids and their receptors, two major members of the
endocannabinoid family, anandamide (AEA) and 2-arachidonoylglycerol (2-AG), have been …

Cannabinoids for gastrointestinal diseases: potential therapeutic applications

GD Carlo, AA Izzo - Expert opinion on investigational drugs, 2003 - Taylor & Francis
Δ9-Tetrahydrocannabinol (the active ingredient of marijuana), as well as endogenous and
synthetic cannabinoids, exert many biological functions by activating two types of …

Endogenous unsaturated C18 N-acylethanolamines are vanilloid receptor (TRPV1) agonists

P Movahed, BAG Jonsson, B Birnir… - Journal of Biological …, 2005 - ASBMB
The endogenous C18 N-acylethanolamines (NAEs) N-linolenoylethanolamine (18: 3 NAE),
N-linoleoylethanolamine (18: 2 NAE), N-oleoylethanolamine (18: 1 NAE), and N …

Pepcan-12 (RVD-hemopressin) is a CB2 receptor positive allosteric modulator constitutively secreted by adrenals and in liver upon tissue damage

V Petrucci, A Chicca, S Glasmacher, J Paloczi, Z Cao… - Scientific reports, 2017 - nature.com
Abstract Pepcan-12 (RVD-hemopressin; RVDPVNFKLLSH) is the major peptide of a family
of endogenous peptide endocannabinoids (pepcans) shown to act as negative allosteric …

Neuropharmacology of the endocannabinoid signaling system-molecular mechanisms, biological actions and synaptic plasticity

BS Basavarajappa - Current neuropharmacology, 2007 - ingentaconnect.com
The endocannabinoid signaling system is composed of the cannabinoid receptors; their
endogenous ligands, the endocannabinoids; the enzymes that produce and inactivate the …

Prostaglandin ethanolamides (prostamides): in vitro pharmacology and metabolism

I Matias, J Chen, L De Petrocellis, T Bisogno… - … of Pharmacology and …, 2004 - ASPET
We investigated whether prostaglandin ethanolamides (prostamides) E2, F2α, and D2 exert
some of their effects by 1) activating prostanoid receptors either per se or after conversion …